Korro Bio Inc. (KRRO)
NASDAQ · Healthcare
Korro Bio Inc. Operating Income 2019–2025
Korro Bio Inc. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Korro Bio Inc. operating income for the quarter ending March 31, 2026 was -20.4 M, a 18.32% decrease year-over-year.
- Korro Bio Inc. operating income for the twelve months ending March 31, 2026 was -91.9 M, a 3.08% increase year-over-year.
- Korro Bio Inc. annual operating income for 2025 was -121.9 M, a 32.58% increase from 2024.
- Korro Bio Inc. annual operating income for 2024 was -91.9 M, a 8.73% increase from 2023.
- Korro Bio Inc. annual operating income for 2023 was -84.5 M, a 43.28% increase from 2022.
- Korro Bio Inc. annual operating income for 2022 was -59.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Korro Bio Inc. Operating Income — FAQ
Korro Bio Inc. (KRRO) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Korro Bio Inc.'s operating income?
Korro Bio Inc. (KRRO) reported operating income of -$122M for fiscal 2025.
Where can I see KRRO's operating income history?
The chart and table above show Korro Bio Inc.'s operating income by year and by quarter, including the growth rate.